HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Bromine → 3-Bromo-7-methoxyimidazo[1,2-a]pyridine

HRID 985530
Print

Reaction equation

HRID 985530 reaction equation
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][N:6]2[CH:9]=[CH:10][N:11]=[C:5]2[CH:4]=1.C([O-])(=O)C.[Na+].[Br:17]Br.C(=O)([O-])O.[Na+]>[Br-].[K+].CO>[Br:17][C:9]1[N:6]2[CH:7]=[CH:8][C:3]([O:2][CH3:1])=[CH:4][C:5]2=[N:11][CH:10]=1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 4

HCID 24408BromineHCID 516892Sodium BicarbonateHCID 517045Sodium AcetateHCID 450881887-Methoxyimidazo[1,2-a]pyridine

Product 1

HCID 547755773-Bromo-7-methoxyimidazo[1,2-a]pyridineYield 26%

Reagents, catalysts & solvents 2

HCID 887
Methanol
Solvent
HCID 253877Potassium BromideSolvent

Conditions

Temperature
0 °C

Procedure

7-Methoxyimidazo[1,2-α]pyridine (1.0 g, 6.8 mmol) and sodium acetate (0.67 g, 8.1 mmol) were dissolved in a saturated solution of potassium bromide in methanol (5 ml) and cooled to 0° C. before adding bromine (1.13 g, 7.1 mmol) dropwise over 5 min. The mixture was allowed to stir for 15 min before pouring onto saturated sodium hydrogencarbonate solution (50 ml). The resulting yellow solid was collected by filtration and dried. This solid was purified by flash column chromatography on silica eluting with 50% ethyl acetate in isohexane to afford 3-bromo-7-methoxyimidazo[1,2-α]pyridine (0.4 g, 26%) as a white solid. 1H NMR (360 MHz, CDCl3) δH 3.87 (3H, s), 6.64 (1H, dd, J 2 and 7), 6.88 (1H, d, J 2), 7.45 (1H, s), 7.92 (1H, d, J 7).

Workup

  1. filtrationThe resulting yellow solid was collected by filtration
  2. customdried
  3. customThis solid was purified by flash column chromatography on silica eluting with 50% ethyl acetate in isohexane

Sources & evidence

ORD record
ord-ab94b565ec104a97b57a7fe7acc65077
Source dataset
uspto-grants-2005_03
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US06872731B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes